Relay Therapeutics Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | |
| – | +32.1% | +24.7% | +10.6% | +5.2% | +27.6% | +3.7% | -125.5% | |
| – | +54.3% | +617.2% | +51.6% | +15.9% | +53.2% | +9.4% | -33.7% | |
| – | -30.4% | +1,463.9% | +62.6% | +9.5% | – | – | – | |
| – | – | -2,076.1% | – | -88.4% | -388.6% | – | -259.4% | |
| – | +374.3% | -75.9% | +79.8% | +161.1% | -54.5% | -51.1% | -79.7% | |
| – | +18,889.5% | – | -687.1% | -60.6% | – | -115.9% | – | |
| – | – | +7,552.8% | -98.6% | -71.3% | – | – | -27.0% | |
| – | – | – | – | – | – | – | – | |
| – | -98.6% | +7,508.1% | -9.0% | -25.3% | -88.0% | +677.4% | -99.4% | |
| – | -208.7% | – | -140.9% | – | – | – | – | |
| – | – | – | – | – | – | – | – |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.